Table 4.

Clinical Outcomes, Baseline ST2 Levels, and Baseline NT-proBNP Levels

30-Day Outcomes	Had Outcome	Did Not Have Outcome	P
Baseline ST2, pg/mL
CV death	325 (42–907)	76 (0–281)	<0.0001
CHF	385 (67–1127)	76 (0–294)	0.0003
CV death or CHF	316 (44–1000)	74 (0–264)	<0.0001
Recurrent MI	74 (0–716)	79 (0–307)	0.56
Stroke	280 (0–778)	78 (0–312)	0.11
NT-proBNP, pg/mL
CV death	455.2 (153–2071)	98.4 (41.2–279.0)	<0.0001
CHF	312.6 (68.7–1765.0)	102.7 (41.5–289.5)	0.0007
CV death or CHF	411.8 (120.0–2071.0)	96.7 (40.6–263.5)	<0.0001
Recurrent MI	70.1 (27.7–131.0)	107.7 (44.1–321.9)	0.0013
Stroke	248.2 (108.1–969.7)	103.1 (42.0–303.2)	0.033

CV indicates cardiovascular. ST2 and NT-proBNP levels are presented as median (25th to 75th percentiles).